Hamilton Process Analytics – Applikon Biotechnology BV and Hamilton Bonaduz AG strengthen business partnership

September 24, 2019

Delft, September 24, 2019 – Dutch-based upstream bioprocess equipment specialist Applikon Biotechnology B.V. (Applikon) and Swiss global manufacturer of precision measurement devices Hamilton Bonaduz AG (Hamilton Process Analytics) jointly announce to have signed a worldwide cooperation agreement, making Hamilton Bonaduz AG a primary supplier for Applikon’s intelligent online measurement and control solutions.

Applikon will act as an independent business party for integrating Hamilton process analytical products including the Arc pH, Dissolved Oxygen and Cell Density sensors to its’ bioprocessing equipment. “We are pleased to have integrated Hamilton process analytical solutions into our standard portfolio. Hamilton Arc technology provides a unique and complete portfolio of sensing solutions for online monitoring all critical process parameters in upstream bioprocess”, stated Arthur Oudshoorn, Managing Director at Applikon. In order to leverage the full potential of Hamilton’s intelligent Arc sensors, Applikon has fully integrated the digital Arc technology in their process control systems.

Hamilton Process Analytics Vice President, Clara Caminada, is pleased that Applikon has chosen Hamilton’s precision measurement devices. “Our complete portfolio of online process analytical products is a perfect add-on to Applikon’s bioreactors. Online monitoring of all critical process parameters online, including cell density, enable process optimization and better processes.”

Both companies look forward to building a closer relationship and to jointly serving customers with a turnkey solution that enables them to improve their upstream bioprocess developments.

About Applikon Biotechnology

Netherlands-based Applikon Biotechnology B.V. (Applikon) is a manufacturer that specializes in upstream bioprocess equipment for the life sciences industries. Its mission is to provide reliable solutions for the bioprocess market to enable improved quality of life.

Applikon’s core business is in the development and supply of advanced bioreactor systems from laboratory scale, to pilot and production scale, partnering with customers to implement scalable platforms from initial screening through development and full-scale production for a global client base that includes pharma and biotech companies, food industry, CROs, CMOs, governmental and academic organizations.

Applikon designs, develops and assembles bioreactor systems, with all design and manufacturing conducted in-house. The Applikon product portfolio covers key product and service areas including bioreactor cultivation systems, BioBundle turnkey systems, the unique BioSep Acoustic Perfusion System cell retention device, process control systems to automate bioprocesses and a range of proprietary Applisens sensors, and automation (monitoring and data management) solutions. Standard process control solutions are based on Emerson DeltaV, Siemens and Allen Bradley PLC systems and our proprietary control platforms.

Apart from its standard cultivation and turnkey systems, Applikon also offers Special Projects: custom solutions aimed at helping clients fulfil strategic needs such as long-term development, capability expansion and upscaling. Applikon is headquartered at Delft in The Netherlands with subsidiaries in the UK, New Jersey and California, USA and a distributor network covering more than 35 countries.

Media Contact Applikon:

Media Department, Applikon Biotechnology B.V

Marjolijn van der Horst, Marketing Manager

Email: press@applikon-biotechnology.com

Website: www.applikon-biotechnology.com